Lisa Danzig

Summary

Affiliation: Chiron Corporation
Country: USA

Publications

  1. ncbi request reprint Meningococcal vaccines
    Lisa Danzig
    Chiron Vaccines, Clinical Research and Medical Affairs, Emeryville, CA 94608 2916, USA
    Pediatr Infect Dis J 23:S285-92. 2004
  2. ncbi request reprint Reverse vaccinology--in search of a genome-derived meningococcal vaccine
    Lisa Danzig
    Clinical Research and Medical Affairs, Chiron Vaccines, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA
    Vaccine 24:S2-11-2. 2006
  3. ncbi request reprint Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children
    Jodie McVernon
    Oxford Vaccine Group, Department of Pediatrics, John Radcliffe Hospital, Oxford, UK
    Pediatr Infect Dis J 21:747-53. 2002
  4. ncbi request reprint Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study
    Scott A Halperin
    Department of Pediatrics, Dalhousie University and the IWK Health Centre, Halifax, NS
    Clin Invest Med 25:243-51. 2002
  5. ncbi request reprint Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years
    Jodie McVernon
    Oxford Vaccine Group, Department of Paediatrics, John Radcliffe Hospital, Headington, UK
    Pediatr Infect Dis J 22:659-61. 2003
  6. pmc Priming for immunologic memory in adults by meningococcal group C conjugate vaccination
    David M Vu
    Children s Hospital Oakland Research Institute, California, USA
    Clin Vaccine Immunol 13:605-10. 2006
  7. ncbi request reprint Immune response to conjugated meningococcal C vaccine in pediatric oncology patients
    Joyce W Yu
    Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, Montreal, Quebec, Canada
    Pediatr Blood Cancer 49:918-23. 2007

Collaborators

Detail Information

Publications7

  1. ncbi request reprint Meningococcal vaccines
    Lisa Danzig
    Chiron Vaccines, Clinical Research and Medical Affairs, Emeryville, CA 94608 2916, USA
    Pediatr Infect Dis J 23:S285-92. 2004
    ..These vaccines were highly effective among adults but were not efficacious among infants and young children. Capsular polysaccharide-protein conjugate vaccines were subsequently developed...
  2. ncbi request reprint Reverse vaccinology--in search of a genome-derived meningococcal vaccine
    Lisa Danzig
    Clinical Research and Medical Affairs, Chiron Vaccines, Chiron Corporation, 4560 Horton Street, Emeryville, CA 94608, USA
    Vaccine 24:S2-11-2. 2006
    ..Genome-based vaccine discovery was evaluated in an attempt to produce a candidate capable of conferring a broadly protective vaccine against a diversity of meningococcal B strains...
  3. ncbi request reprint Safety and immunogenicity of meningococcus serogroup C conjugate vaccine administered as a primary or booster vaccination to healthy four-year-old children
    Jodie McVernon
    Oxford Vaccine Group, Department of Pediatrics, John Radcliffe Hospital, Oxford, UK
    Pediatr Infect Dis J 21:747-53. 2002
    ..Little information exists regarding antibody persistence or immunologic memory after infant vaccination or response to a first dose at 4 years...
  4. ncbi request reprint Simultaneous administration of meningococcal C conjugate vaccine and diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b conjugate vaccine in children: a randomized double-blind study
    Scott A Halperin
    Department of Pediatrics, Dalhousie University and the IWK Health Centre, Halifax, NS
    Clin Invest Med 25:243-51. 2002
    ..The objective of this study was to measure the safety and immunogenicity of a meningococcal C conjugate vaccine when given with routine childhood vaccines...
  5. ncbi request reprint Immunologic memory with no detectable bactericidal antibody response to a first dose of meningococcal serogroup C conjugate vaccine at four years
    Jodie McVernon
    Oxford Vaccine Group, Department of Paediatrics, John Radcliffe Hospital, Headington, UK
    Pediatr Infect Dis J 22:659-61. 2003
    ..A rapid 1000-fold rise in postimmunization bactericidal antibody titers, a measured either 7 or 14 days later, suggested previous immunologic priming...
  6. pmc Priming for immunologic memory in adults by meningococcal group C conjugate vaccination
    David M Vu
    Children s Hospital Oakland Research Institute, California, USA
    Clin Vaccine Immunol 13:605-10. 2006
    ..MCV vaccination of meningococcal vaccine-naïve adults primes for robust memory antibody responses. There was no evidence of induction of memory by MCV in adults previously vaccinated with MPSV...
  7. ncbi request reprint Immune response to conjugated meningococcal C vaccine in pediatric oncology patients
    Joyce W Yu
    Division of Pediatric Allergy and Clinical Immunology, McGill University Health Centre, Montreal, Quebec, Canada
    Pediatr Blood Cancer 49:918-23. 2007
    ..We examined the response of pediatric oncology patients during or following maintenance chemotherapy and post-bone-marrow transplantation to Meningococcal C vaccine...